Payment overview · 2025
General Payments
$45.60
3 reported records · 3 companies
Healthcare provider profile · identity verified
Adam Duran, MD
Allopathic & Osteopathic Physicians|Family Medicine · CARTHAGE, TX · NPI 1265675706
Verified facts
What the public records show
CMS Open Payments records show Adam Duran, MD received $45.60 in general payments during 2025 across 3 reported records.
Acella Pharmaceuticals, LLC accounted for 35.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 121 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Acella Pharmaceuticals, LLC | Unresolved — no canonical attribution shown | $15.95 | 35.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.78 | 34.6% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $13.87 | 30.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $45.60 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NP Thyroid 60 Normalized: np thyroid 60 |
Drug | Acella Pharmaceuticals, LLC | $15.95 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $15.78 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $13.87 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $13.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 121 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
121 | 32 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 571 | 164 |
| Atorvastatin Calcium | Atorvastatin Calcium | 518 | 153 |
| Lisinopril | Lisinopril | 488 | 138 |
| Levothyroxine Sodium | Levothyroxine Sodium | 410 | 118 |
| Gabapentin | Gabapentin | 387 | 93 |
| Pantoprazole Sodium | Pantoprazole Sodium | 351 | 110 |
| Metformin Hcl | Metformin Hcl | 261 | 79 |
| Hydrochlorothiazide | Hydrochlorothiazide | 244 | 70 |
| Ezetimibe | Ezetimibe | 227 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 206 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 205 | 48 |
| Furosemide | Furosemide | 203 | 66 |
| Losartan Potassium | Losartan Potassium | 203 | 61 |
| Alprazolam | Alprazolam | 201 | 37 |
| Simvastatin | Simvastatin | 199 | 59 |
| Clonazepam | Clonazepam | 187 | 25 |
| Potassium Chloride | Potassium Chloride | 185 | 52 |
| Tramadol Hcl | Tramadol Hcl | 173 | 54 |
| Montelukast Sodium | Montelukast Sodium | 167 | 47 |
| Omeprazole | Omeprazole | 155 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 154 | 56 |
| Lorazepam | Lorazepam | 152 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 146 | 36 |
| Glipizide | Glipizide | 143 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 143 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 139 | 35 |
| Trazodone Hcl | Trazodone Hcl | 137 | 39 |
| Pregabalin | Pregabalin | 133 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 130 | 40 |
| Celecoxib | Celecoxib | 127 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 125 | 38 |
| Eliquis | Apixaban | 121 | 32 |
| Sertraline Hcl | Sertraline Hcl | 121 | 39 |
| Carvedilol | Carvedilol | 114 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 30 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 110 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 101 | 22 |
| Temazepam | Temazepam | 100 | 16 |
| Jardiance | Empagliflozin | 99 | 26 |
| Mounjaro | Tirzepatide | 97 | 20 |
| Allopurinol | Allopurinol | 94 | 27 |
| Fenofibric Acid | Fenofibric Acid (Choline) | 86 | 20 |
| Fenofibrate | Fenofibrate,micronized | 82 | 24 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 78 | 11 |
| Metformin Hcl Er | Metformin Hcl | 78 | 22 |
| Glipizide Er | Glipizide | 77 | 23 |
| Meloxicam | Meloxicam | 77 | 23 |
| Symbicort | Budesonide/Formoterol Fumarate | 76 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 76 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 74 | 23 |
| Ozempic | Semaglutide | 71 | 14 |
| Synthroid | Levothyroxine Sodium | 71 | 21 |
| Valsartan | Valsartan | 71 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 68 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 67 | 22 |
| Alendronate Sodium | Alendronate Sodium | 66 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 66 | 18 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 64 | 13 |
| Methylprednisolone | Methylprednisolone | 63 | 54 |
| Warfarin Sodium | Warfarin Sodium | 63 | 14 |
| Cephalexin | Cephalexin | 61 | 48 |
| Farxiga | Dapagliflozin Propanediol | 60 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 59 | 48 |
| Dutasteride | Dutasteride | 59 | 17 |
| Famotidine | Famotidine | 59 | 21 |
| Propranolol Hcl | Propranolol Hcl | 59 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 58 | 18 |
| Atenolol | Atenolol | 56 | 19 |
| Progesterone | Progesterone, Micronized | 55 | suppressed |
| Chlorthalidone | Chlorthalidone | 54 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 53 | 14 |
| Topiramate | Topiramate | 53 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 52 | 16 |
| Diazepam | Diazepam | 50 | 12 |
| Azithromycin | Azithromycin | 49 | 42 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | 15 |
| Tradjenta | Linagliptin | 48 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 48 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 46 | suppressed |
| Nystatin | Nystatin | 45 | 21 |
| Trulicity | Dulaglutide | 44 | 11 |
| Spironolactone | Spironolactone | 43 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 42 | 13 |
| Donepezil Hcl | Donepezil Hcl | 40 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 39 | suppressed |
| Estradiol | Estradiol | 39 | 11 |
| Nifedipine Er | Nifedipine | 38 | 12 |
| Testosterone Cypionate | Testosterone Cypionate | 38 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 37 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 37 | suppressed |
| Glimepiride | Glimepiride | 37 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 35 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 35 | 26 |
| Solifenacin Succinate | Solifenacin Succinate | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 26 |
| Baclofen | Baclofen | 31 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 31 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 28 | 11 |
| Finasteride | Finasteride | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 27 | 17 |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Prednisone | Prednisone | 26 | 18 |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 22 | suppressed |
| Methocarbamol | Methocarbamol | 21 | 16 |
| Sucralfate | Sucralfate | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Memantine Hcl | Memantine Hcl | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Ranolazine Er | Ranolazine | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Vraylar | Cariprazine Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | 13 |
| Fluconazole | Fluconazole | 15 | 13 |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Invokana | Canagliflozin | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 12 |
| Norethindron-Ethinyl Estradiol | Norethindrone Ac/Eth Estradiol | 13 | suppressed |
| Np Thyroid | Thyroid,pork | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Estradiol-Norethindrone Acetat | Estradiol/Norethindrone Acet | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Digoxin | Digoxin | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Mirtazapine | Mirtazapine | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $45.60 · 3 records | Acella Pharmaceuticals, LLC | ELIQUIS, NP Thyroid 60, NURTEC ODT, The Cologuard Plus Collection Kit | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error